XOMA Royalty Corp
XOMA26.960USD
+0.850+3.26%
Handelsschluss 07/03, 13:00（ET）Kurse um 15 Minuten verzögert
322.25MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über XOMA Royalty Corp Unternehmen
XOMA Royalty Corporation is a biotechnology royalty aggregator. The Company’s royalty aggregator business is primarily focused on early to mid-stage clinical assets, primarily in Phase I and II, with significant commercial sales potential that are licensed to funded partners. The Company has a portfolio of economic rights and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The Company's royalty portfolio includes OJEMDA (tovorafenib), Cetrelimab (JNJ-63723283), Ersodetug (RZ358), MIPLYFFATM (arimoclomol), Acimtamig (AFM13), Ficlatuzumab (AV-299), COM902, Vosaroxin, Aldoxorubicin, PBF-680, PBF-677, PBF-999, PBF-1129, PBF-1650, DSUVIA (sufentanil sublingual tablet), IXINITY, Vidutolimod (CMP-001), MT-0169, RZ-402, G03-52-0, AFM24, Mezagitamab (TAK-079), among others. The Company also acquires milestone and royalty revenue streams on late-stage or commercial assets.
Unternehmensinformationen
BörsenkürzelXOMA
Name des UnternehmensXOMA Royalty Corp
IPO-datumJun 06, 1986
Gegründet am2011
CEOMr. Owen P. Hughes, Jr.
Anzahl der mitarbeiter13
WertpapierartOrdinary Share
GeschäftsjahresendeJun 06
Addresse2200 Powell Street
StadtEMERYVILLE
BörseNASDAQ Global Market Consolidated
LandUnited States of America
Postleitzahl94608
Telefon15102047239
Websitehttps://www.xoma.com/
BörsenkürzelXOMA
IPO-datumJun 06, 1986
Gegründet am2011
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Jack L. Wyszomierski
Mr. Jack L. Wyszomierski
Independent Chairman of the Board
Independent Chairman of the Board
12.44K
+92.36%
Mr. Joseph M. (Joe) Limber
Mr. Joseph M. (Joe) Limber
Independent Director
Independent Director
6.21K
-0.03%
Ms. Natasha A. Hernday
Ms. Natasha A. Hernday
Independent Director
Independent Director
5.97K
--
Ms. Heather L. Franklin
Ms. Heather L. Franklin
Independent Director
Independent Director
5.97K
--
Mr. Thomas (Tom) Burns
Mr. Thomas (Tom) Burns
Chief Financial Officer, Senior Vice President - Finance
Chief Financial Officer, Senior Vice President - Finance
--
--
Ms. Barbara A. Kosacz, J.D.
Ms. Barbara A. Kosacz, J.D.
Independent Director
Independent Director
--
--
Mr. Matthew D. Perry
Mr. Matthew D. Perry
Independent Director
Independent Director
--
--
Mr. Owen P. Hughes, Jr.
Mr. Owen P. Hughes, Jr.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Bradley J. (Brad) Sitko
Mr. Bradley J. (Brad) Sitko
Chief Investment Officer
Chief Investment Officer
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Jack L. Wyszomierski
Mr. Jack L. Wyszomierski
Independent Chairman of the Board
Independent Chairman of the Board
12.44K
+92.36%
Mr. Joseph M. (Joe) Limber
Mr. Joseph M. (Joe) Limber
Independent Director
Independent Director
6.21K
-0.03%
Ms. Natasha A. Hernday
Ms. Natasha A. Hernday
Independent Director
Independent Director
5.97K
--
Ms. Heather L. Franklin
Ms. Heather L. Franklin
Independent Director
Independent Director
5.97K
--
Mr. Thomas (Tom) Burns
Mr. Thomas (Tom) Burns
Chief Financial Officer, Senior Vice President - Finance
Chief Financial Officer, Senior Vice President - Finance
--
--
Ms. Barbara A. Kosacz, J.D.
Ms. Barbara A. Kosacz, J.D.
Independent Director
Independent Director
--
--
Umsatzaufteilung
Währung: USDAktualisiert: Wed, Jul 2
Währung: USDAktualisiert: Wed, Jul 2
FY2025Q1
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
Keine Daten
Nach RegionUSD
Name
Umsatz
Anteil
United States
6.09M
38.30%
Switzerland
5.82M
36.56%
Asia Pacific
4.00M
25.14%
Nach Geschäftsbereich
Nach Region
Keine Daten
Aktionärsstatistik
Aktualisiert: Thu, May 22
Aktualisiert: Thu, May 22
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
BVF Partners L.P.
21.65%
Morgan Stanley Investment Management Inc. (US)
9.23%
Fidelity Management & Research Company LLC
8.68%
BlackRock Institutional Trust Company, N.A.
4.10%
The Vanguard Group, Inc.
3.84%
Other
52.51%
Aktionäre
Aktionäre
Anteil
BVF Partners L.P.
21.65%
Morgan Stanley Investment Management Inc. (US)
9.23%
Fidelity Management & Research Company LLC
8.68%
BlackRock Institutional Trust Company, N.A.
4.10%
The Vanguard Group, Inc.
3.84%
Other
52.51%
Aktionärstypen
Aktionäre
Anteil
Hedge Fund
26.12%
Investment Advisor/Hedge Fund
18.89%
Investment Advisor
17.15%
Individual Investor
1.34%
Research Firm
0.34%
Pension Fund
0.08%
Bank and Trust
0.07%
Insurance Company
0.02%
Other
35.99%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
147
7.66M
64.02%
+67.58K
2025Q1
150
7.99M
66.81%
+297.02K
2024Q4
151
7.96M
67.53%
-445.61K
2024Q3
149
7.79M
66.29%
-572.80K
2024Q2
143
7.78M
66.74%
-664.29K
2024Q1
144
7.71M
66.30%
-615.38K
2023Q4
149
7.62M
66.29%
-820.22K
2023Q3
146
7.80M
68.02%
-670.64K
2023Q2
148
7.93M
69.11%
+32.68K
2023Q1
155
7.51M
65.57%
+97.45K
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
BVF Partners L.P.
2.59M
21.65%
-392.72K
-13.17%
May 16, 2025
Morgan Stanley Investment Management Inc. (US)
1.10M
9.23%
+811.40K
+277.18%
Mar 31, 2025
Fidelity Management & Research Company LLC
1.04M
8.68%
-1.68K
-0.16%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
490.59K
4.1%
-8.20K
-1.64%
Mar 31, 2025
The Vanguard Group, Inc.
459.09K
3.84%
-4.75K
-1.02%
Mar 31, 2025
Opaleye Management Inc.
253.04K
2.11%
+3.04K
+1.22%
Mar 31, 2025
Geode Capital Management, L.L.C.
186.67K
1.56%
+4.48K
+2.46%
Mar 31, 2025
Woodline Partners LP
168.55K
1.41%
+12.28K
+7.86%
Mar 31, 2025
State Street Global Advisors (US)
144.73K
1.21%
+200.00
+0.14%
Mar 31, 2025
Stonepine Capital Management, LLC
129.81K
1.08%
+4.11K
+3.27%
Mar 31, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Wed, Jul 2
Aktualisiert: Wed, Jul 2
Name
Anteil
iShares Micro-Cap ETF
0.04%
ProShares Hedge Replication ETF
0.01%
iShares Russell 2000 ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
iShares Russell 2000 Value ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Global X Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
Avantis US Equity ETF
0%
Avantis US Small Cap Equity ETF
0%
Mehr Anzeigen
iShares Micro-Cap ETF
Anteil0.04%
ProShares Hedge Replication ETF
Anteil0.01%
iShares Russell 2000 ETF
Anteil0.01%
iShares Russell 2000 Growth ETF
Anteil0.01%
iShares Russell 2000 Value ETF
Anteil0.01%
ProShares UltraPro Russell2000
Anteil0.01%
Global X Russell 2000 ETF
Anteil0.01%
Proshares Ultra Russell 2000
Anteil0.01%
Avantis US Equity ETF
Anteil0%
Avantis US Small Cap Equity ETF
Anteil0%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
